Aamod Rao Retatrutide vs Ozempic: Triple-Action Retatrutide vs Ozempic-the triple-action weight-loss shot targeting GLP-1, GIP and glucagon
Current Topics in Membranes, 84 , 6798
"By combining trusted clinical expertise with the reach of our digital and pharmacy network, we're helping eligible patients take meaningful steps toward better health, on their own terms." The launch comes amid sustained consumer demand for GLP-1 medications
In addition, the secondary end points in SUSTAIN-6 included: Time from randomization to first occurrence of an expanded composite CV outcome (defined as either EAC-confirmed MACE, revascularization (coronary and peripheral), unstable angina requiring hospitalization or hospitalization for heart failure)
Consent for publication Informed consent was obtained from all individual participants included in the study